IP Library Granted Patent US 11,351,168
Granted Patent B1
US 11,351,168 · App. 16/825,285 · Granted Jun 7, 2022

2,4-disubstituted pyrimidines useful as kinase inhibitors

Inventors: Juswinder Singh (Southborough, MA); Russell C. Petter (Stow, MA); Richland Wayne Tester (Marlborough, MA); Arthur F. Kluge (Lincoln, MA); Hormoz Mazdiyasni (Marlborough, MA); William Frederick Westlin, III (Boxborough, MA); Deqiang Niu (Lexington, MA); Lixin Qiao (Andover, MA)
Assignee: Celgene CAR LLC
A61K31/505A61K31/506A61K31/519A61K31/538A61K31/5377A61K31/541A61K45/06C07D239/47C07D239/48C07D401/12C07D401/14C07D403/12C07D405/12C07D405/14C07D407/12C07D413/12C07D413/14C07D471/04C07D487/04C07D487/08C07D487/18C07D495/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,351,168
App. No.
16/825,285
Granted
Jun 7, 2022
Kind
B1
Abstract

The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.

Claims (4)

1. A method for inhibiting the activity of Janus kinase 3, or a mutant thereof, in a patient or in a biological sample comprising the step of administering to the patient or contacting the biological sample with a compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

2. The method according to claim 1 , wherein the activity of the Janus kinase 3, or a mutant thereof, is inhibited irreversibly.

3. The method according to claim 2 , wherein the activity of the Janus kinase 3, or a mutant thereof, is inhibited irreversibly by covalently modifying Cys909 of Janus kinase 3.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded May 3, 2023
From: CELGENE CAR LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 063526/0959 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2020
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.; MAZDIYASNI, HORMOZ; WESTLIN, WILLIAM FREDERICK, III; NIU, DEQIANG; QIAO, LIXIN
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 052982/0312 →
MERGER AND CHANGE OF NAME Recorded Jun 18, 2020
From: CELGENE AVILOMICS RESEARCH, INC.; CELGENE CAR LLC
To: CELGENE CAR LLC
Reel/Frame 052982/0330 →
Continuity (9)
Division 16024514 · Jun 29, 2018
Division 15221421 · Jul 27, 2016
Division 14253903 · Apr 16, 2014
Continuation 13667396 · Nov 2, 2012
Division 12648693 · Dec 29, 2009
Continuation In Part 12492180 · Jun 26, 2009
Provisional Application 61170874 · Apr 20, 2009
Provisional Application 61148388 · Jan 29, 2009
Provisional Application 61076450 · Jun 27, 2008
Cited By (2)
US 12,421,221 US 12,441,707